Patterson Companies (PDCO) Receives a Hold from Robert W. Baird

By Austin Angelo

Robert W. Baird analyst Jeff Johnson reiterated a Hold rating on Patterson Companies (PDCOResearch Report) today and set a price target of $22.00. The company’s shares closed last Monday at $23.10.

According to TipRanks.com, Johnson is a 5-star analyst with an average return of 21.3% and a 69.6% success rate. Johnson covers the Healthcare sector, focusing on stocks such as Zimmer Biomet Holdings, Wright Medical Group, and Tandem Diabetes Care.

The word on The Street in general, suggests a Moderate Sell analyst consensus rating for Patterson Companies with a $20.00 average price target.

See today’s analyst top recommended stocks >>

Based on Patterson Companies’ latest earnings release for the quarter ending October 31, the company reported a quarterly GAAP net loss of $33.13 million. In comparison, last year the company had a net profit of $28.87 million.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Patterson Cos., Inc. engages in dental and animal health supplies. It operates through the following segments: Dental, Animal Health, and Corporate. The Dental segment provides a virtually complete range of consumable dental products, equipment and software, turnkey digital solutions an value-added services to dentists and dental laboratories.